Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Fintel reports that on November 14, 2024, B of A Securities downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from ...

Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...

Shares of Hims&Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty ...

Amazon said that Prime members will have access to new fixed pricing for the treatment of ailments including erectile dysfunction and men’s hair loss, as part of its most recent effort to compete with ...

In response to the announcement, the stock of Hims & Hers—a company specializing in telehealth and subscription-based wellness products—plunged as investors weighed the impact of Amazon’s ...

Hims & Hers (HIMS) similarly connects patients ... We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.